These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26992127)

  • 1. The modified iron avidity index: a promising phenotypic predictor in HFE-related haemochromatosis.
    Verhaegh PL; Moris W; Koek GH; van Deursen CT
    Liver Int; 2016 Oct; 36(10):1535-9. PubMed ID: 26992127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitors Reduce the Frequency of Phlebotomy in Patients With Hereditary Hemochromatosis.
    van Aerts RM; van Deursen CT; Koek GH
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):147-52. PubMed ID: 26240005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Pump Inhibitors Decrease Phlebotomy Need in HFE Hemochromatosis: Double-Blind Randomized Placebo-Controlled Trial.
    Vanclooster A; van Deursen C; Jaspers R; Cassiman D; Koek G
    Gastroenterology; 2017 Sep; 153(3):678-680.e2. PubMed ID: 28624580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
    Kowdley KV; Modi NB; Peltekian K; Vierling JM; Ferris C; Valone FH; Gupta S
    Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1118-1128. PubMed ID: 37863080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.
    Ong SY; Gurrin LC; Dolling L; Dixon J; Nicoll AJ; Wolthuizen M; Wood EM; Anderson GJ; Ramm GA; Allen KJ; Olynyk JK; Crawford D; Ramm LE; Gow P; Durrant S; Powell LW; Delatycki MB
    Lancet Haematol; 2017 Dec; 4(12):e607-e614. PubMed ID: 29195602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis.
    Hutchinson C; Geissler CA; Powell JJ; Bomford A
    Gut; 2007 Sep; 56(9):1291-5. PubMed ID: 17344278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: a follow-up study.
    Milet J; Le Gac G; Scotet V; Gourlaouen I; Thèze C; Mosser J; Bourgain C; Deugnier Y; Férec C
    Blood Cells Mol Dis; 2010 Jan; 44(1):34-7. PubMed ID: 19879168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis.
    Kelleher T; Ryan E; Barrett S; Sweeney M; Byrnes V; O'Keane C; Crowe J
    Gut; 2004 Aug; 53(8):1174-9. PubMed ID: 15247188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors reduce phlebotomy burden in patients with HFE-related hemochromatosis: a systematic review and meta-analysis.
    Dirweesh A; Anugwom CM; Li Y; Vaughn BP; Lake J
    Eur J Gastroenterol Hepatol; 2021 Oct; 33(10):1327-1331. PubMed ID: 32769410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis.
    Wood MJ; Crawford DHG; Wockner LF; Powell LW; Ramm GA
    Liver Int; 2017 Sep; 37(9):1382-1388. PubMed ID: 28231420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
    Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y
    Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
    Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
    Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
    Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
    Barton JC; Barton EH; Acton RT
    BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemochromatosis.
    Adams PC; Barton JC
    Lancet; 2007 Dec; 370(9602):1855-60. PubMed ID: 18061062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using iron studies to predict HFE mutations in New Zealand: implications for laboratory testing.
    O'Toole R; Romeril K; Bromhead C
    Intern Med J; 2017 Apr; 47(4):447-454. PubMed ID: 28019068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
    van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
    Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
    Phatak PD; Barton JC
    Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do pregnancies reduce iron overload in HFE hemochromatosis women? results from an observational prospective study.
    Scotet V; Saliou P; Uguen M; L'Hostis C; Merour MC; Triponey C; Chanu B; Nousbaum JB; Le Gac G; Ferec C
    BMC Pregnancy Childbirth; 2018 Feb; 18(1):53. PubMed ID: 29454332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.